Topics
Gliomas | Treatment | Targeted therapy | Dabrafenib
Home > Publications > Topics > Gliomas > Treatment > Targeted therapy > Dabrafenib
Lei J, Liu Y, Fan Y.
The effects of
dabrafenib and/or trametinib treatment in Braf V600-mutant glioma:
a systematic review and meta-analysis.
Neurosurg
Rev. 2024 Aug 22;47(1):458. doi:
10.1007/s10143-024-02664-x. PMID:
39172230. Review; Meta-analysis. ˍ
Chellapandian H, Jeyachandran S.
Letter
to Editor, "The effects of dabrafenib and/or trametinib
treatment in Braf V600mutant glioma: a systematic review and
metaanalysis".
Neurosurg
Rev. 2024 Sep 14;47(1):613. doi:
10.1007/s10143-024-02858-3. PMID:
39271502. Review; Meta-analysis˰
ˍ
Hajikarimloo B, Habibi MA, Kooshki A, Alvani MS, Zare AH,
Hasanzade A, Zare AH, Akhlaghpasand M, Tavanaei R, Tos
SM.
Dabrafenib plus trametinib in
low-grade versus
high-grade gliomas: a systematic review and meta-analysis.
BMC
Cancer. 2024 Nov 29;24(1):1473. doi:
10.1186/s12885-024-13229-y. PMID:
39614165. Review; Meta-analysis. ˍ